대시보드포트폴리오관심 목록커뮤니티발견스크리너
NOT FOR DISTRIBUTION

Evolv Technologies Holdings, Inc.

NasdaqCM:EVLV 주식 리포트

시가총액: US$893.0m

  • 회사 개요
  • 가치 평가
  • 미래 성장
  • 과거 실적
  • 재무 건전성
  • 배당
  • 경영진
  • 지분
  • 기타 정보
  • 주식 커뮤니티

Evolv Technologies Holdings 향후 성장

Future 기준 점검 1/6

Evolv Technologies Holdings 의 수익은 연간 35.5% 감소할 것으로 예상되는 반면, 연간 수익은 17.4% 로 증가할 것으로 예상됩니다. EPS는 연간 34.1% 만큼 쇠퇴할 것으로 예상됩니다.

핵심 정보

-35.5%

이익 성장률

-34.13%

EPS 성장률

Electronic 이익 성장26.2%
매출 성장률17.4%
향후 자기자본이익률n/a
애널리스트 커버리지

Low

마지막 업데이트08 Sep 2026

최근 향후 성장 업데이트

Recent updates

User avatar
내러티브 업데이트 • Sep 08

EVLV: 2026 Manufacturing Ramp And New Contracts Will Drive Upside

Analysts have trimmed their fair value estimate for Evolv Technologies Holdings from $10.00 to $8.00. This aligns it with a new $8.00 price target that reflects updated assumptions for revenue growth, profit margins and future P/E expectations following recent research coverage.
분석 기사 • Jun 21

Evolv Technologies Holdings (EVLV) Stock Could Be 43.5% Undervalued After DHS SAFETY Act Designation

Evolv Technologies Holdings (EVLV) is back in focus after the US Department of Homeland Security granted SAFETY Act Designation to its Evolv eXpedite bag screening system, placing both core products on the Qualified Anti-Terrorism Technologies list. See our latest analysis for Evolv Technologies Holdings. Even with the SAFETY Act news drawing fresh attention, Evolv Technologies Holdings’ share price has been under pressure in 2026, with the year to date share price return down 15.67% and the...
User avatar
내러티브 업데이트 • Jun 16

EVLV: SAFETY Act Wins And 2026 Manufacturing Ramp Will Drive Upside

Analysts have maintained their consolidated price target for Evolv Technologies Holdings at $10.50, citing recent Q1 results, clarification of misreported data, and commentary on revenue trends, margins, and longer term manufacturing benefits as key supports for this level. Analyst Commentary on Evolv Technologies Holdings Recent research coverage on Evolv Technologies Holdings centers on the Q1 report, the clarification of misreported information via an 8-K filing, and updated views on revenue growth, margins, and longer term manufacturing plans.
User avatar
내러티브 업데이트 • Jun 02

EVLV: 2026 Contract Manufacturing Ramp Will Drive Long Term Upside

Analysts have nudged their average price target on Evolv Technologies Holdings higher from $9.50 to $10.00, pointing to what they see as strong Q1 execution, improved RPO growth, and the potential for 2026 to mark a positive inflection in growth and profitability, despite recent share price dislocation linked to reporting confusion. Analyst Commentary Recent research highlights a generally constructive stance on Evolv Technologies Holdings after Q1, with several firms pointing to what they see as strong execution, raised guidance, and improving contract metrics such as remaining performance obligations.
User avatar
내러티브 업데이트 • May 02

EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside

Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
User avatar
내러티브 업데이트 • Apr 18

EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
User avatar
내러티브 업데이트 • Apr 03

EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside

Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.
User avatar
내러티브 업데이트 • Mar 20

EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside

Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.
User avatar
내러티브 업데이트 • Mar 06

EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).
User avatar
내러티브 업데이트 • Feb 20

EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026

Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.
User avatar
내러티브 업데이트 • Feb 05

EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case

Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.
User avatar
내러티브 업데이트 • Jan 22

EVLV: ARR Momentum Will Set Up A Breakout Year In 2026

Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.
User avatar
내러티브 업데이트 • Jan 08

EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook

Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.
User avatar
내러티브 업데이트 • Dec 14

EVLV: ARR Momentum Will Drive A Breakout Year In 2026

Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.
User avatar
내러티브 업데이트 • Aug 16

Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets

The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.
User avatar
새로운 내러티브 • Jun 01

AI Screening Will Expand Public Safety Applications

Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.
분석 기사 • May 21

The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%

Unfortunately for some shareholders, the Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has dived 28% in...

이익 및 매출 성장 예측

NasdaqCM:EVLV - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
12/31/2028274-13N/A641
12/31/2027219-378425
12/31/2026182-362245
6/30/2026171-5-628N/A
3/31/2026160-36-1018N/A
12/31/2025146-33-1819N/A
9/30/2025137-60-356N/A
6/30/2025121-88-256N/A
3/31/2025114-44-47-17N/A
12/31/2024104-54-68-31N/A
9/30/202495-55-85-37N/A
6/30/202489-21-101-39N/A
3/31/202483-91-102-23N/A
12/31/202380-108-82-10N/A
9/30/202377-120-71-12N/A
6/30/202376-142-77-31N/A
3/31/202365-101-80-49N/A
12/31/202253-87-99-75N/A
9/30/202241-53-110-84N/A
6/30/202233-14-113-91N/A
3/31/202228-11-97-74N/A
12/31/202123-11-74-57N/A
9/30/202119-25-61-47N/A
6/30/202112-52-41-28N/A
3/31/20218-35-36-27N/A
12/31/20205-27-30-23N/A
12/31/20196-20N/A-15N/A

애널리스트 향후 성장 전망

수입 대 저축률: EVLV 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: EVLV 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: EVLV 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: EVLV 의 수익(연간 17.4%)이 US 시장(연간 13.5%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: EVLV 의 수익(연간 17.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.


주당순이익 성장 예측


향후 자기자본이익률

미래 ROE: EVLV의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.


성장 기업 찾아보기

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/09/10 05:10
종가2026/09/10 00:00
수익2026/06/30
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
  • SEC 양식 10-K
  • SEC 양식 10-Q
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
  • 분석가 리서치 보고서
  • Blue Matrix
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
  • ICE 시장 데이터
  • SEC 양식 S-1
지분 구조10년
  • 주요 주주
  • 내부자 거래
  • SEC 양식 4
  • SEC 양식 13D
경영진10년
  • 리더십 팀
  • 이사회
  • SEC 양식 10-K
  • SEC 양식 DEF 14A
주요 개발10년
  • 회사 공시
  • SEC 양식 8-K

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Evolv Technologies Holdings, Inc.는 5명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Jeremy HamblinCraig-Hallum Capital Group LLC
Eric MartinuzziLake Street Capital Markets, LLC
Michael LatimoreNorthland Capital Markets

어디서든 더 나은 투자 결정을 내리세요

스캔하여 다운로드
App Store 열기Google Play 열기
Chrome 웹 스토어
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
데이터 소스 보기
시장
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
투자 아이디어
  • 저평가 기업
  • 고배당 우량주
  • 임원 매수
  • 원자력 에너지
  • 자율주행차
  • 인공지능
  • 암호화폐 및 블록체인
  • 사이버보안
  • 더 많은 아이디어
주식 커뮤니티
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
기능 및 도구
  • 포트폴리오 추적기
  • 주식 스크리너 & 알림
  • 내러티브 및 적정 가치
  • 배당 계산기
뉴스 및 탐색
  • 최신 주식 뉴스
  • 글로벌 시장 인사이트
  • 더 폭스홀
  • 투자 아이디어
  • 커뮤니티 스토리
  • 새로운 소식
Simply Wall St
  • 플랜 및 가격
  • 광고
  • 회사 소개
  • 문의하기
  • 채용
  • 도움말 센터
  • 주식 투자 학습
  • 제휴 프로그램
  • 비즈니스 & 엔터프라이즈
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • 이용 약관
  • 개인정보처리방침
  • AI 약관
  • 금융 서비스 가이드